Mate Health

What Mate Health does

Mate Health (legal entity MATE HEALTH LLC) is a U.S.-based health technology company operating from Lombard, Illinois, that sells clinical-grade at-home semen analysis kits direct to consumers and through a clinician ordering channel. Its portfolio comprises three products: a Comprehensive Semen Analysis at $249 reporting 20 clinical semen parameters; an Advanced Semen Analysis at $440 adding DNA Fragmentation Index via Sperm Chromatin Dispersion and vitality testing with microscopy imaging; and a Post-Vasectomy Analysis at $199 with detection sensitivity to 0.01 M/mL. Every kit is shipped via FedEx Priority Overnight under the company's Active Cooling transport system, which uses a proprietary semen preservative validated across 222 live specimens (R² of 0.90–0.98 across 10 parameters) to maintain specimens below 15°C for up to 34 hours.

Specimens are processed by Medical Electronic Systems (MES), a third-party CLIA-certified, CAP-accredited high-complexity andrology laboratory operating under WHO 6th Edition (2021) methodology and directed by William Roudebush, PhD, HCLD. Results are returned within 24 hours through a secure patient and physician portal, accompanied by MateIQ—an AI-powered interpretation tool that contextualizes the patient's actual values against curated peer-reviewed andrology literature and the company's reference ranges.

The business model is one-time unit pricing at three tiers ($199/$249/$440) plus a $45 vitality add-on, with HSA/FSA eligibility. Distribution combines a Shopify-based D2C storefront (mate.health), a physician portal with QR-code ordering for urologists, OB/GYNs, fertility specialists, and primary care clinicians, and an affiliate program. The company is privately held with no disclosed institutional funding and operates with a small team led by co-founders Paul Jurgensen (CEO, former Abbott senior commercial leader) and Ashmit Pyakurel (CTO). Shipments reach 47 U.S. states, with New York, Alaska, Hawaii, and Puerto Rico excluded.

Name

Mate Health

Legal name

MATE HEALTH LLC

Website

https://mate.health

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Mate Health sells clinical-grade at-home semen analysis kits (Comprehensive, Advanced, and Post-Vasectomy) direct to consumers and via a physician portal, processed through a CLIA-certified, CAP-accredited partner lab using validated temperature-controlled transport and AI-driven MateIQ report interpretation.

Ownership category

akta.pro rank

Product category

At-Home Fertility Diagnostics

NAICS

Medical and Diagnostic Laboratories (62151)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Testing Laboratories (8734)

akta.pro primary industry

Sample Logistics, Biorepository & IVD Kit Management (Trial Support) (HLAGAEAI)

Keywords

• At-home fertility testing
• Male fertility diagnostics
• Semen analysis kits
• Reproductive health testing
• Clinical laboratory services

Headquarters

HQ city

Lombard

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Operations, Supply Chain, Marketing or Sales, Technology or R&D, Personnel, Infrastructure

Revenue model

1. Direct-to-Consumer At-Home Testing Kits: Mate Health generates revenue through direct sales of at-home semen analysis kits to consumers via its e-commerce platform. Customers purchase one of three test kits: Comprehensive ($249), Advanced ($440), or Post-Vasectomy ($199). Additional revenue comes from add-on vitality testing ($45). Kits are HSA/FSA eligible.
2. Physician/Clinic Orders: Clinicians can order tests for patients through the physician portal. The kit ships directly to the patient, and results are delivered through the secure portal to both the patient and physician.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Mate Health sells clinical-grade at-home semen analysis kits directly to consumers and through physicians. Specimens are collected at home and shipped under a proprietary temperature-controlled Active Cooling transport system to a CLIA-certified, CAP-accredited high-complexity andrology laboratory that reports 20+ semen parameters, with optional DNA fragmentation and vitality testing, and AI-powered result interpretation via MateIQ. Results are delivered within 24 hours through a secure portal in both patient-friendly and physician formats.

Product overview

Mate Health offers a portfolio of three clinical-grade at-home semen analysis tests processed in a CLIA-certified, CAP-accredited high-complexity andrology laboratory. The core products are: (1) At-Home Comprehensive Semen Analysis ($249) reporting 20 semen parameters with four motility classifications, morphology, velocity, and 10 derived functional sperm metrics, with optional $45 Vitality Testing add-on; (2) At-Home Advanced Semen Analysis ($440) adding DNA Fragmentation Index (DFI) via Sperm Chromatin Dispersion (SCD) assay and vitality testing with sperm microscopy images for physician review; and (3) At-Home Post-Vasectomy Analysis ($199) with 0.01 M/mL detection sensitivity for post-vasectomy clearance confirmation. All products include Active Cooling transport (maintained below 15°C for up to 34 hours), WHO 6th Edition (2021) methodology, and MateIQ — an AI-powered report interpretation tool that synthesizes patient results with curated peer-reviewed andrology and fertility sources. Results are delivered within 24 hours through a secure portal, formatted for both patient and physician review.

Differentiator

Problem solved

Functional benefit

Products and services

• At-Home Comprehensive Semen Analysis

Quantifiable outcome

• Up to 20% of men with unexplained infertility and normal routine semen parameters may have elevated DNA fragmentation
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

One partnership is on record.

• Medical Electronic Systems, LLC (MES)coreTechnology or IntegrationMedical Electronic Systems (MES) provides third-party laboratory testing services for Mate Health. MES performs the actual semen analysis testing as a certified clinical laboratory partner.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Posterity Health: Male fertility clinic and telehealth platform that focuses on specialist-driven male evaluation rather than pure at-home testing — comparable target market and physician-channel dynamic, with partial overlap in clinical workflow.

Broad incumbents

• Labcorp: Large clinical laboratory network offering traditional in-person semen analysis through physician orders — a broad incumbent providing the clinic-based alternative to Mate Health's at-home model.
• Ro: Telehealth platform offering men's health and fertility services as part of a broader portfolio — a broad incumbent whose men's-health category overlaps Mate Health's positioning and consumer base.
• Hims & Hers Health: Public telehealth company offering men's health services including fertility-related testing and treatment — a much broader incumbent whose men's-health category overlaps with Mate Health's target consumer.

Direct peers

• Bird&Be: At-home fertility testing for couples covering both male and female parameters, with physician-backed content and a premium DTC positioning that overlaps Mate Health's couples-trying-to-conceive segment.
• Fellow: At-home male fertility testing and sperm storage company selling direct-to-consumer kits with clinician integration — directly comparable product, customer base, and D2C-plus-physician GTM model.
• Legacy: Direct-to-consumer at-home sperm analysis and freezing service with overlapping male-fertility positioning, similar premium pricing tier, and both consumer and clinical channels — the closest head-to-head competitor to Mate Health.
• Trak (Sandstone Diagnostics): Maker of the Trak at-home male fertility testing system with its own collection device — a direct competitor in the at-home semen-analysis category with overlapping consumer and clinical audiences.

Others

• Carrot Fertility: Fertility benefits platform sold to employers — adjacent rather than directly competitive, but its payer-side position influences how employers steer employees toward at-home testing providers like Mate Health.
• Progyny: Enterprise fertility benefits and clinic-network provider — adjacent ecosystem player whose employer-covered fertility benefits can either include or compete with at-home male fertility testing services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/mate-health

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mate Health